(Q33947205)

30 July 2017

1 reference

title

The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors (English)

1 reference

30 July 2017

Li Q

1

1 reference

30 July 2017

Mitscher LA

series ordinal

2

1 reference

30 July 2017

Shen LL

series ordinal

3

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Medicinal Research Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

231-293

1 reference

Therapeutic advances of new fluoroquinolones

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Gram-positive resistance: challenge for the development of new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Enterococci and vancomycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Research and development of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

New directions in antibacterial research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Antibacterials - mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant Gram-positive bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Oxazolidinones: new antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Structural modifications of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Novelties in the field of anti-infectives in 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

The chemistry and biological profile of trovafloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Design, synthesis, and properties of (4S)-7-(4-amino-2-substituted-pyrrolidin-1-yl)quinolone-3-carboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Studies on antibacterial agents. III. Synthesis and antibacterial activities of substituted 1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

The mechanism of inhibition of topoisomerase IV by quinolone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Topoisomerase IV is a target of quinolones in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Crystal structure of the breakage-reunion domain of DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural basis of protein splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

A model for the mechanism of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Recent developments in DNA topoisomerase II structure and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Antibiotic resistance in oral/respiratory bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Bacterial resistance: a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Antibiotic resistance--what can we do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Vancomycin resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Penicillin-resistant pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

United States geographic bacteria susceptibility patterns. 1996 ASCP Susceptibility Testing Group. American Society of Clinical Pathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Antibiotic resistance in respiratory pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 24-27, 1998, San Diego, CA, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Structure-activity relationships among DNA gyrase inhibitors. Synthesis and biological evaluation of 1,2-dihydro-4,4-dimethyl-1-oxo-2-naphthalenecarboxylic acids as 1-carba bioisosteres of oxolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Synthesis and structure-activity relationships of 2-pyridones: II. 8-(Fluoro-substituted pyrrolidinyl)-2-pyridones as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-8-alkoxyquinolone antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

Protein gates in DMA topoisomerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200007%2920%3A4%3C231%3A%3AAID-MED1%3E3.0.CO%3B2-N

10.1002/1098-1128(200007)20:4<231::AID-MED1>3.0.CO;2-N

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference